


The perfect start into the Bravecto® family with a 1-month combination chewable tablet for dogs
Protect dogs against common internal and external parasites with a combination product.
Provide the right protection from the start against important parasites with BRAVECTO®

Kills fleas and ticks

Treats roundworms and hookworms

Prevents lungworm disease and heartworm disease

Safety demonstrated for dogs 8 weeks of age or older and weighing at least 1.27 kg*


Formulated with trusted ingredients
BRAVECTO TriUNO contains fluralaner, moxidectin and pyrantel (as embonate) – three proven ingredients that together provide broad spectrum protection and help reduce the risk of vector-borne disease.1
- Provides a perfect start for puppies into the Bravecto family, moving to Bravecto long duration options from 6 months of age for tailored year-round protection
- Reduces the risk of infection with Babesia canis canis†
- Reduces the risk of infection with Dipylidium caninum†
- Can be used as part of a treatment strategy for flea allergic dermatitis (FAD)
Frequently asked questions
BRAVECTO TriUNO indications:
Flea (Ctenocephalides felis and C. canis) and tick (Dermacentor reticulatus, Ixodes hexagonus, I. ricinus, and Rhipicephalus sanguineus) killing activity for 1 month.
For reduction of the risk of infection with Babesia canis via transmission by D. reticulatus for 1 month. The effect is indirect due to the product’s activity against the vector.
For reduction of the risk of infection with Dipylidium caninum via transmission by C. felis for 1 month.
Treatment of infections with gastrointestinal nematodes of the following species:
roundworms (adult stages of Toxocara canis and Toxascaris leonina), hookworms (L4, immature adult (L5) and adult stages of Ancylostoma caninum and adult stages of Uncinaria stenocephala).
Prevention of heartworm disease (caused by Dirofilaria immitis).
Prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
BRAVECTO TriUNO is a flavoured chewable tablet that is given at home by the dog owner each month at or around the time of feeding.
BRAVECTO TriUNO’s safety has been demonstrated for dogs 8 weeks of age and older and weighing at least 1.27 kg.*
The addition of BRAVECTO TriUNO provides practices with even more choice and flexibility. The BRAVECTO family now provides clinical choice of 1-month, 12-week or 1-year duration products in variable application methods. BRAVECTO TriUNO is a perfect start for puppies, with the flexibility to move to long duration protection from 6 months of age as their lifestyle changes.
No matter the pet’s life stage or lifestyle, client preference, or compliance challenge, ONLY the BRAVECTO portfolio offers a full range of products designed specifically to provide easy and lasting protection to your canine and feline patients.
The Bravecto family now provides you and your practice with clinical choice between 1 year, 12 weeks and 1 month treatment options depending on the pet’s lifestyle needs. Bravecto TriUNO is a perfect start for puppies into the Bravecto family, with the flexibilty from 6 months to transition into long duration protection and risk based worming.
Fluralaner, the active ingredient in BRAVECTO, is rapidly absorbed and is distributed systemically into tissues. Fluralaner is not metabolised to a major extent and is mainly excreted unchanged in the faeces.2
The active ingredients in BRAVECTO TriUNO are well-known and trusted. Fluralaner, one of the world’s most prescribed flea and tick preventives, is the foundation of the BRAVECTO portfolio with a trusted safety profile for more than 10 years. Pyrantel and moxidectin have both been used to treat parasites in dogs for decades.
All animals 6 months of age or older, living in or having travelled to areas where infected vectors exist, should be tested for existing adult heartworm infections before beginning preventive use with the veterinary medicinal product with BRAVECTO TriUNO.




ONE BRAND.
MANY PATHS TO PARASITE PROTECTION.
Ask your MSD Animal Health representative about the full range of BRAVECTO parasite solutions for your practice.

All pets. All ages. All Lifestyles.
Always Bravecto.
When it comes to meeting the diverse needs of your practice and pets, BRAVECTO delivers.
1 year, 12 weeks and 1 month treatment options giving vets clinical choice to deliver year-round protection for every pet’s lifestyle with Always Bravecto®
CONTACT US TO DELIVER combination PARASITE PROTECTION IN YOUR PRACTICE
We will answer your questions to ensure you are ready to prescribe BRAVECTO TriUNO to help keep your patients healthy and their owners happy.
“*” indicates required fields
REFERENCES
1. BRAVECTO TriUNO DATA SHEET: https://www.noahcompendium.co.uk/?id=-488422&fromsearch=true#iosfirsthighlight
2. BRAVECTO. Summary of Product Characteristics. https://medicines.health.europa.eu/veterinary/en/search-medicines?keys=Bravecto
*Adverse events observed included gastrointestinal effects, lethargy and hypersalivation. These effects were mild and transient.
† For reduction of the risk of infection with B canis via transmission by Dermacentor reticulatus for one month. The effect is indirect due to the product’s activity against the vector. For reduction of the risk of infection with D caninum via transmission by Ctenocephalides felis for one month. The effect is indirect due to the product’s activity against the vector.